CD45+CD326+ Cells are Predictive of Poor Prognosis in Non-Small Cell Lung Cancer Patients.
Kota IshizawaMie YamanakaYuriko SaikiEisaku MiyauchiShinichi FukushigeTetsuya AkaishiAtsuko AsaoTakahiro MimoriRyota SaitoYutaka TojoRiu YamashitaMichiaki AbeAkira SakuradaNhu-An PhamMing LiYoshinori OkadaTadashi IshiiNaoto IshiiSeiichi KobayashiMasao NagasakiMasakazu IchinoseMing Sound TsaoAkira HoriiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
In conclusion, varying percentages of CD45/CD326 DPC exist in both solid cancer tissue and malignant pleural effusion in patients with NSCLC. This CD45/CD326 doubly-positive subpopulation can be an important key to clinical management of patients with NSCLC.
Keyphrases
- poor prognosis
- small cell lung cancer
- long non coding rna
- end stage renal disease
- newly diagnosed
- ejection fraction
- induced apoptosis
- advanced non small cell lung cancer
- chronic kidney disease
- papillary thyroid
- squamous cell carcinoma
- cell cycle arrest
- squamous cell
- signaling pathway
- cell death
- tyrosine kinase
- epidermal growth factor receptor
- pi k akt